Acadia Pharmaceuticals Inc. ACAD
17.49 USD -0.10 (-0.59%)
As ofNov 20, 2026, 12:01 PM EST
17.46 Day range 17.62
15.86 52-week range 30.96
- YTD
- -34.54%
- 1 year
- -23.64%
Held by funds
172 US ETFs and mutual funds hold ACAD · largest positions
- NIR 0.16% of fund $166.50M
- IJR 0.14% of fund $145.85M
- VTI 0.00% of fund $66.72M
- NJM 0.08% of fund $63.17M
- IWM 0.08% of fund $62.33M
- VB 0.03% of fund $59.61M
- XBI 0.48% of fund $47.24M
- FSSNX 0.12% of fund $40.78M
- VBK 0.08% of fund $33.40M
- VXF 0.03% of fund $30.15M
- IBB 0.23% of fund $24.81M
- NLT 0.33% of fund $24.06M
- IWO 0.17% of fund $22.64M
- SPSM 0.14% of fund $22.20M
- DFAS 0.07% of fund $22.16M
- NLO 0.15% of fund $22.14M
- IJT 0.30% of fund $21.71M
- VSEQX 0.15% of fund $18.30M
- VTSIX 0.15% of fund $16.72M
- VTWO 0.09% of fund $15.61M
Ownership
- Institutions 98.4%
- Insiders 0.33%
- Public and other holders 1.22%
Held by insiders 0.33%
Held by institutions 98.44%
Float held by institutions 98.77%
Institutions 475
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baker Bros. Advisors, LP | 24.83% | 42,912,904 | 754.41M | Sep 29, 2026 |
| Blackrock Inc. | 13.28% | 22,947,481 | 403.42M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 5.47% | 9,457,124 | 166.26M | Sep 29, 2026 |
| State Street Corporation | 4.43% | 7,650,889 | 134.50M | Sep 29, 2026 |
| RTW Investments LP | 4.13% | 7,144,524 | 125.60M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 3.35% | 5,790,801 | 101.80M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 4.45% | 7,694,693 | 135.27M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.36% | 4,074,465 | 71.63M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.93% | 3,329,826 | 58.54M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.71% | 2,949,287 | 51.85M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.43% | 2,472,502 | 43.47M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 0.98% | 1,699,377 | 29.88M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADAMS CATHERINE OWEN | Chief Executive Officer | Sale | Mar 24, 2026 | 14,803 |
| BAKER BROS ADVISORS L.P. | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | May 28, 2026 | 0 |
| BAKER BROTHERS LIFE SCIENCES L P | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | May 28, 2025 | 0 |
| BREGE LAURA A | Director | Conversion of Exercise of derivative security | May 28, 2026 | 23,202 |
| GAROFALO ELIZABETH AMY M.D. | Director | Conversion of Exercise of derivative security | May 28, 2026 | 33,489 |
| HARRIGAN EDMUND P. M.D. | Director | Conversion of Exercise of derivative security | May 28, 2026 | 43,148 |
